Healthcare - Sector
CTMX is currently covered by 9 analysts with an average price target of $12.78. This is a potential upside of $10.75 (529.56%) from yesterday's end of day stock price of $2.03.
CytomX Therapeutics's activity chart (see below) currently has 100 price targets and 99 ratings on display. The stock rating distribution of CTMX is 94.12% BUY and 5.88% HOLD.
Analysts' price targets on this stock were met 32.53% of the time, taking 123.28 days on average.
Highest price target for CTMX is $16, Lowest price target is $10, average price target is $12.78.
Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 12-Nov-2026. First documented stock forecast 02-Nov-2015.
Currently out of the existing stock ratings of CTMX, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-Aug-2026
$12
$9.97 (491.13%)
$11
10 days ago
(12-Nov-2026)
0/5 (0%)
$9.96 (488.24%)
Buy Since 17-Mar-2026
$12
$9.97 (491.13%)
$11
16 days ago
(06-Nov-2026)
2/6 (33.33%)
$9.81 (447.95%)
87
Buy Since 09-Mar-2026
$14
$11.97 (589.66%)
$15
3 months 12 days ago
(10-Aug-2026)
0/4 (0%)
$10.56 (306.98%)
Buy Since 20-May-2025
$11
$8.97 (441.87%)
$10
6 months 11 days ago
(11-May-2026)
2/4 (50%)
$7.14 (184.97%)
244
Buy Since 10-Nov-2025
$12
$9.97 (491.13%)
$10
7 months 30 days ago
(23-Mar-2026)
1/3 (33.33%)
$7.54 (169.06%)
126
What is CTMX (CytomX Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on CTMX (CytomX Therapeutics)?
Which analyst has the most public recommendations on CTMX (CytomX Therapeutics)?
Which analyst is the currently most bullish on CTMX (CytomX Therapeutics)?
Which analyst is the currently most reserved on CTMX (CytomX Therapeutics)?